Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Aphria Inc.
Bullboard Posts
User Avatar Image
(12)
•••
Post by quietobserveron Oct 04, 2019 12:07pm
150 Views
Post# 30196885

Zacks sales estimate

Zacks sales estimate

Sales Estimates

  Current Qtr
(8/2019)		 Next Qtr
(11/2019)		 Current Year
(5/2020)		 Next Year
(5/2021)
Zacks Consensus Estimate 103.90M 113.11M 503.75M 709.97M
# of Estimates 2 2 4 5
High Estimate 104.35M 113.13M 514.18M 766.81M
Low Estimate 103.44M 113.09M 494.91M 667.09M
Year ago Sales 10.15M 16.58M 178.08M 503.75M
Year over Year Growth Est. 923.60% 582.21% 182.87% 40.94%

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities